Oil drops, sending U.S. prices down by more than 1% for the week
China includes U.S. crude in retaliatory tariffs
All Posts in "Market Watch"
Interest rate cuts could make these bonds an attractive target
Home-builder bonds, not often seen as ‘defensive,’ get bullish lift from Fed cut and wage growth
HP stock falls on analyst downgrade following CEO departure, weak outlook
As ratings games go, this one is pretty much X-rated.
Dow ends more than 600 points lower as U.S.-China trade war intensifies
Trump ‘orders’ U.S. firms to look for alternatives to China after Beijing imposes retaliatory tariffs
HP Inc. names head of printer division as new CEO
Shares fall despite quarterly boost in PC shipments
Boeing’s shares buoy Dow industrials but broader stock market ends lower ahead of Powell speech
Boeing delivers a 98-point jolt to the Dow
These 4 big blue chip stocks are cheap for a reason, cautions money manager
Critical information for the U.S. trading day
Salesforce stock surges as results, outlook top Street estimates
Full-year revenue outlook raised following acquisitions
Gold retreats as the U.S. stock market strengthens, traders await Fed minutes for clues on interest rates
Fed will publish minutes of July 30-31 meeting at 2 p.m. ET
Europe stocks edge lower as Fed looks hesitant
European stocks drifted lower on Thursday, after indications that the U.S. Federal Reserve last month wasn’t aggressively looking to cut interest rates in the world’s largest economy.
Weekly Market Review – January 4, 2025
Orion to use Aitia’s ‘digital twins’ to identity potential new cancer drugs
Windtree’s cardiogenic shock med raises blood pressure in latest phase 2 win
Merck’s Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
New PicnicHealth service brings observational clinical trial research to the virtual world
OncoC4 founders take own science under their wing in new biotech merger
BioAge Labs aims to raise $180M from IPO, private placement to fund obesity trials
Amgen reports first phase 3 win for $400M eczema drug, but Dupixent rivalry doubts remain
Clinical trial site network Headlands Research opens new location in El Paso, Texas
NewHold Investment Corp. III Files to Offer Up to 20M Units in IPO